• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

限制平均生存时间的基线协变量调整方法比较。

Comparison of baseline covariate adjustment methods for restricted mean survival time.

机构信息

Biometrics Department, R&D Division, Kyowa Kirin Co., Ltd., Otemachi Financial City Grand Cube, 1-9-2 Otemachi, Chiyoda-ku, Tokyo.

Biometrics Department, R&D Division, Kyowa Kirin Co., Ltd., Otemachi Financial City Grand Cube, 1-9-2 Otemachi, Chiyoda-ku, Tokyo; The Institute of Statistical Mathematics, 10-3 Midori-cho, Tachikawa, Tokyo 190-8562, Japan.

出版信息

Contemp Clin Trials. 2024 Mar;138:107440. doi: 10.1016/j.cct.2024.107440. Epub 2024 Jan 14.

DOI:10.1016/j.cct.2024.107440
PMID:38228232
Abstract

The restricted mean survival time provides a straightforward clinical measure that dispenses with the need for proportional hazards assumptions. We focus on two strategies to directly model the survival time and adjust covariates. Firstly, pseudo-survival time is calculated for each subject using a leave-one-out approach, followed by a model analysis that adjusts for covariates using all pseudo-values. This method is used to reflect information of censored subjects in the model analysis. The second approach adjusts for covariates for those subjects with observed time-to-event while incorporating censored subjects using inverse probability of censoring weighting (IPCW). This paper evaluates these methods' power to detect group differences through computer simulations. We find the interpretation of pseudo-values challenging with the pseudo-survival time method and confirm that pseudo-survival times deviate from actual data in a primary biliary cholangitis clinical trial, mainly due to extensive censoring. Simulations reveal that the IPCW method is more robust, unaffected by the balance of censors, whereas pseudo-survival time is influenced by this balance. The IPCW method retains a nominal significance level for the type-1 error rate, even amidst group differences concerning censor incidence rates and covariates. Our study concludes that IPCW and pseudo-survival time methods differ significantly in handling censored data, impacting parameter estimations. Our findings suggest that the IPCW method provides more robust results than pseudo-survival time and is recommended, even when censor probabilities vary between treatment groups. However, pseudo-survival time remains a suitable choice when censoring probabilities are balanced.

摘要

限制平均生存时间提供了一种直接的临床衡量标准,无需进行比例风险假设。我们专注于两种直接对生存时间建模并调整协变量的策略。首先,使用留一法为每个对象计算伪生存时间,然后使用所有伪值进行模型分析以调整协变量。这种方法用于反映模型分析中删失对象的信息。第二种方法是在对观察到的事件时间进行调整的同时,使用逆概率 censoring 加权(Inverse Probability of Censoring Weighting,IPCW)来调整具有观察到的事件时间的对象的协变量。本文通过计算机模拟评估了这些方法检测组间差异的能力。我们发现伪生存时间方法对伪值的解释具有挑战性,并在原发性胆汁性胆管炎临床试验中证实了伪生存时间与实际数据存在偏差,主要是由于广泛的 censoring。模拟表明,IPCW 方法更稳健,不受 censors 平衡的影响,而伪生存时间则受此平衡的影响。即使在 censors 发生率和协变量方面存在组间差异,IPCW 方法仍能保持名义水平的第一类错误率。我们的研究得出结论,IPCW 和伪生存时间方法在处理 censored 数据方面存在显著差异,影响参数估计。我们的研究结果表明,IPCW 方法比伪生存时间提供了更稳健的结果,即使在censors 概率在治疗组之间存在差异时,也建议使用。然而,当 censors 概率平衡时,伪生存时间仍然是一个合适的选择。

相似文献

1
Comparison of baseline covariate adjustment methods for restricted mean survival time.限制平均生存时间的基线协变量调整方法比较。
Contemp Clin Trials. 2024 Mar;138:107440. doi: 10.1016/j.cct.2024.107440. Epub 2024 Jan 14.
2
Two-stage estimation to adjust for treatment switching in randomised trials: a simulation study investigating the use of inverse probability weighting instead of re-censoring.两阶段估计调整随机试验中的治疗转换:一项使用逆概率加权而不是重新分类来调整的模拟研究。
BMC Med Res Methodol. 2019 Mar 29;19(1):69. doi: 10.1186/s12874-019-0709-9.
3
Doubly robust estimator of risk in the presence of censoring dependent on time-varying covariates: application to a primary prevention trial for coronary events with pravastatin.存在与时间相关的协变量的删失依赖性下风险的双重稳健估计:普伐他汀治疗冠心病一级预防试验的应用。
BMC Med Res Methodol. 2020 Jul 31;20(1):204. doi: 10.1186/s12874-020-01087-8.
4
Model selection for survival individualized treatment rules using the jackknife estimator.利用刀切估计量进行生存个体化治疗规则的模型选择。
BMC Med Res Methodol. 2022 Dec 22;22(1):328. doi: 10.1186/s12874-022-01811-6.
5
The net benefit for time-to-event outcome in oncology clinical trials with treatment switching.肿瘤临床试验中因治疗转换而导致的时间事件结局的净获益。
Clin Trials. 2023 Dec;20(6):670-680. doi: 10.1177/17407745231186081. Epub 2023 Jul 16.
6
Performance of Restricted Mean Survival Time Based Methods and Traditional Survival Methods: An Application in an Oncological Data.基于受限平均生存时间的方法与传统生存方法的性能比较:在肿瘤学数据中的应用。
Comput Math Methods Med. 2022 Dec 28;2022:7264382. doi: 10.1155/2022/7264382. eCollection 2022.
7
Regression modeling of restricted mean survival time for left-truncated right-censored data.左截断右删失数据的限制平均生存时间的回归建模。
Stat Med. 2022 Jul 20;41(16):3003-3021. doi: 10.1002/sim.9399. Epub 2022 Mar 28.
8
Restricted mean survival time regression model with time-dependent covariates.具有时依协变量的限制平均生存时间回归模型。
Stat Med. 2022 Sep 20;41(21):4081-4090. doi: 10.1002/sim.9495. Epub 2022 Jun 23.
9
Estimation of treatment effect adjusting for dependent censoring using the IPCW method: an application to a large primary prevention study for coronary events (MEGA study).使用逆概率删失加权法(IPCW)对依存性删失进行调整后的治疗效果估计:在一项大型冠心病一级预防研究(MEGA研究)中的应用
Clin Trials. 2007;4(4):318-28. doi: 10.1177/1740774507081224.
10
Calibration plots for multistate risk predictions models.多状态风险预测模型的校准图。
Stat Med. 2024 Jun 30;43(14):2830-2852. doi: 10.1002/sim.10094. Epub 2024 May 8.